The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Open accessAbstract
BACKGROUND.: The purpose of this study was to investigate whether tumor‐infiltrating immune cells in biopsy specimens can be used to predict the clinical outcome of stage IV nonsmall cell lung cancer (NSCLC) patients. METHOD.: The authors performed an immunohistochemical study to identify and count the number of CD68+ macrophages, c‐kit+ mast cells, and CD8+ T cells in both cancer nests and cancer stroma in pretreatment biopsy specimens obtained from 199 patients with stage IV NSCLC treated by chemotherapy, and then analyzed for correlations between the number of immune cells and clinical outcome, including chemotherapy response and prognosis. RESULTS.: There was no correlation between the number of immune cells in either cancer nests or stroma and chemotherapy response. Patients with more tumor‐infiltrating macrophages in cancer nests than in cancer stroma (macrophages, nests > stroma) had significantly better survival than nests < stroma cases median survival time (MST 440 days vs 199 days; P < .0001). Patients with more tumor‐infiltrating CD8+ T cells in cancer nests than in cancer stroma (CD8+ T cells: nests > stroma) showed significantly better survival than in nests < stroma cases (MST 388 days vs 256 days; P = .0070). The proportion of tumor‐infiltrating macrophages or CD8+ T cells between cancer nests and stroma became independent prognostic factors in the multivariate analysis. Neither the number of mast cells in nests nor in stroma correlated with the clinical outcome. CONCLUSIONS.: Evaluation of the numbers of macrophages and CD8+ T cells in cancer nests and stroma are useful biomarkers for predicting the prognosis of stage IV NSCLC patients treated with chemotherapy, but could fail to predict chemotherapy response. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Self-citationKelly, K., Crowley, J., Bunn, P. A., Presant, C. A., Grevstad, P. K., Moinpour, C. M., Ramsey, S. D., Wozniak, A. J., Weiss, G. R., Moore, D. F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3210 · Cited by 1,123
(2000) · PubMed · Cited by 706
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 552
Fukunaga, A., Miyamoto, M., Cho, Y., Murakami, S., Kawarada, Y., Oshikiri, T., Kato, K., Kurokawa, T., Suzuoki, M., Nakakubo, Y., et al. (2004) · Pancreas · doi:10.1097/00006676-200401000-00023 · Cited by 532
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
Schumacher, K., Haensch, W., Röefzaad, C., & Schlag, P. M. (2001) · PubMed · Cited by 503
Hiraoka, K., Miyamoto, M., Cho, Y., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., Ohbuchi, T., Kondo, S., & Katoh, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602934 · Cited by 481
Mast cells and angiogenesis: Review article
Norrby, K. (2002) · APMIS · doi:10.1034/j.1600-0463.2002.100501.x · Cited by 381
Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression
Chen, J. J. W., Lin, Y.-C., Yao, P.-L., Yuan, A., Chen, H.-Y., Shun, C.-T., Tsai, M.-F., Chen, C.-H., & Yang, P.-C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.172 · Cited by 374
Welsh, T. J., Green, R. H., Richardson, D., Waller, D. A., O'Byrne, K. J., & Bradding, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4910 · Cited by 369
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 366
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., & Harris, A. L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4<430::aid-path538>3.0.co;2-6 · Cited by 322
Cho, Y., Miyamoto, M., Kato, K., Fukunaga, A., Shichinohe, T., Kawarada, Y., Hida, Y., Oshikiri, T., Kurokawa, T., Suzuoki, M., et al. (2003) · PubMed · Cited by 246
Ohno, S., Inagawa, H., Dhar, D. K., Fujii, T., Ueda, S., Tachibana, M., Suzuki, N., Inoue, M., Soma, G., & Nagasue, N. (2003) · PubMed · Cited by 171
Kataki, A., Scheid, P., Piet, M., Marie, B., Martinet, N., Martinet, Y., & Vignaud, J.-M. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.128317 · Cited by 166
Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?
Bunn, P. A. (2002) · PubMed · Cited by 154
Supernatural T cells: genetic modification of T cells for cancer therapy
Kershaw, M. H., Teng, M. W. L., Smyth, M. J., & Darcy, P. K. (2005) · Nature reviews. Immunology · doi:10.1038/nri1729 · Cited by 150
Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis
Yano, H., Kinuta, M., Tateishi, H., Nakano, Y., Matsui, S., Monden, T., Okamura, J., Sakai, M., & Okamoto, S. (1999) · Gastric Cancer · doi:10.1007/s101200050017 · Cited by 129
Clinical significance of immune cell infiltration within gallbladder cancer
Nakakubo, Y., Miyamoto, M., Cho, Y., Hida, Y., Oshikiri, T., Suzuoki, M., Hiraoka, K., Itoh, T., Kondo, S., & Katoh, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601331 · Cited by 117
Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system.
Henderson, W. R., Chi, E. Y., Jong, E. C., & Klebanoff, S. J. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.3.520 · Cited by 117
Fisher, E. R., Paik, S., Rockette, H. E., Jones, J., Caplan, R. J., & Fisher, B. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90180-9 · Cited by 115
Oshikiri, T., Miyamoto, M., Shichinohe, T., Suzuoki, M., Hiraoka, K., Nakakubo, Y., Shinohara, T., Itoh, T., Kondo, S., & Katoh, H. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10321 · Cited by 104
Ribatti, D., Finato, N., Crivellato, E., Marzullo, A., Mangieri, D., Nico, B., Vacca, A., & Beltrami, C. A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.04.055 · Cited by 102
Mouse mast cells as anti-tumor effector cells
Farram, E., & NELSON, D. S. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90162-8 · Cited by 93
Aaltomaa, S. H., Lipponen, P., Papinaho, S., & Kosma, V. M. (1993) · PubMed · Cited by 74
In vitro generated mast cells express natural cytotoxicity against tumour cells.
GHIARA, P., Boraschi, D., Villa, L., Scapigliati, G., Taddei, C., & Tagliabue, A. (1985) · PubMed · Cited by 54
Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma
Tomita, M., Matsuzaki, Y., & Onitsuka, T. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00076-8 · Cited by 53
Macrophage infiltration and angiogenesis in endometrial cancer.
Hashimoto, I., Kodama, J., Seki, N., Hongo, A., Miyagi, Y., Yoshinouchi, M., & Kudo, T. (2000) · PubMed · Cited by 45
Ashida, A., Boku, N., Aoyagi, K., Sato, H., Tsubosa, Y., Minashi, K., Muto, M., Ohtsu, A., Ochiai, A., Yoshida, T., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.6.1345 · Cited by 43
Self-citationDonskov, F. N., Bennedsgaard, K. M., Hokland, M., Marcussen, N., Fisker, R. V., Madsen, H. H. T., Fode, K., & von der Maase, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0525-9 · Cited by 42
Håkansson, A., Gustafsson, B., Krysander, L., Hjelmqvist, B., Rettrup, B., & Håkansson, L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2169 · Cited by 26
Bernengo, M. G., Quaglino, P., Cappello, N., Lisa, F., Osella‐Abate, S., & T., F. M. (2000) · Melanoma Research · doi:10.1097/00008390-200010010-00008 · Cited by 18
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146
Shang, B., Liu, Y., Jiang, S.-J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep15179 · Cited by 985
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Savas, P., Salgado, R., Denkert, C., Sotiriou, C., Darcy, P. K., Smyth, M. J., & Loi, S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.215 · Cited by 890
Metadata
- Authors
- Kawai, O., Ishii, G., Kubota, K., Murata, Y., Naito, Y., Mizuno, T., Aokage, K., Saijo, N., Nishiwaki, Y., Gemma, A., Kudoh, S., & Ochiai, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-07-31
- Volume
- 113
- Issue
- 6
- Pages
- 1387-1395
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2089220120
- Cited by
- 384
- References
- 38
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.